Insulet Corporation (NASDAQ: PODD) received clearance from the U.S. Food and Drug Administration (FDA) for its Omnipod® 5 Automated Insulin Delivery System. Up over 12% Shares of Insulet Corporation (NASDAQ: PODD) gained over 12.9% during the premarket trading session following...
Cue Biopharma, Inc. (NASDAQ: CUE) reported clinical update during yesterday’s conference call. According to the clinical-stage biopharmaceutical company reported early data in the combination study...
Vaccinex, Inc. (Nasdaq: VCNX) reported its interim response data in the Phase Ib segment of the KEYNOTE-B84 study earlier today. Results from Study The KEYNOTE-B84...
Sierra Oncology, Inc. (NASDAQ: SRRA) announced positive data from the pivotal Phase 3 MOMENTUM study. The study housed a double blind clinical trial that evaluates...
Mind Medicine Inc. (NASDAQ: MNMD) has seen its Investigational New Drug application cleared by the FDA, opening the door for the company’s Phase 2b dose-optimization...
Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) shares jumped more than 13% Tuesday after the clinical-stage immunotherapy and targeted oncology company announced positive topline results from its...
Valneva SE (NASDAQ: VALN), a specialty vaccine company, announced Thursday results from an initial laboratory study demonstrating that serum antibodies induced by three doses of...
Aptorum Group Limited (NASDAQ: APM) has announced that the United States Food and Drug Administration Office has granted Orphan Drug Designation to SACT-1, small molecule...
Zogenix (NASDAQ: ZGNX) and UCB has reported entry into a definitive agreement where UCB will acquire all outstanding shares of Zogenix for USD 26 per...
NeuroMetrix, Inc. (NASDAQ: NURO) stock jumped about 40% after the healthcare company announced that its Quell® technology has received Breakthrough Designation from the U.S. Food...
Rockwell Medical, Inc. (Nasdaq: RMTI) received regulatory approval today from the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea for its...
Immuron Limited (NASDAQ: IMRN) today announced that it had received funding for a new research agreement with the U.S Department of Defense. Up Premarket Shares...
United Airlines (NASDAQ: UAL) is reducing its schedule due to a surge in ill employees, according to a memo sent out by CEO Scott Kirby....
Jan 28, 2022 by MarketDepth